UK health performance: Findings of the Global Burden of Disease Study 2010

Christopher J.L. Murray*, Michael A. Richards, John N. Newton, Kevin Fenton, H. Ross Anderson, Charles Atkinson, Derrick Bennett, Eduardo Bernabé, Hannah Blencowe, Rupert Bourne, Tasanee Braithwaite, Carol Brayne, Nigel G. Bruce, Traolach S. Brugha, Peter Burney, Mukesh Dherani, Helen Dolk, Karen Edmond, Majid Ezzati, Abraham D. FlaxmanTom D. Fleming, Greg Freedman, David Gunnell, Roderick J. Hay, Sally J. Hutchings, Summer Lockett Ohno, Rafael Lozano, Ronan A. Lyons, Wagner Marcenes, Mohsen Naghavi, Charles R. Newton, Neil Pearce, Dan Pope, Lesley Rushton, Joshua A. Salomon, Kenji Shibuya, Theo Vos, Haidong Wang, Hywel C. Williams, Anthony D. Woolf, Alan D. Lopez, Adrian Davis

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    403 Citations (Scopus)


    Background The UK has had universal free health care and public health programmes for more than six decades. Several policy initiatives and structural reforms of the health system have been undertaken. Health expenditure has increased substantially since 1990, albeit from relatively low levels compared with other countries. We used data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2010 (GBD 2010) to examine the patterns of health loss in the UK, the leading preventable risks that explain some of these patterns, and how UK outcomes compare with a set of comparable countries in the European Union and elsewhere in 1990 and 2010. Methods We used results of GBD 2010 for 1990 and 2010 for the UK and 18 other comparator nations (the original 15 members of the European Union, Australia, Canada, Norway, and the USA; henceforth EU15+). We present analyses of trends and relative performance for mortality, causes of death, years of life lost (YLLs), years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE). We present results for 259 diseases and injuries and for 67 risk factors or clusters of risk factors relevant to the UK. We assessed the UK's rank for age-standardised YLLs and DALYs for their leading causes compared with EU15+ in 1990 and 2010. We estimated 95% uncertainty intervals (UIs) for all measures. Findings For both mortality and disability, overall health has improved substantially in absolute terms in the UK from 1990 to 2010. Life expectancy in the UK increased by 4•2 years (95% UI 4•2-4•3) from 1990 to 2010. However, the UK performed significantly worse than the EU15+ for age-standardised death rates, age-standardised YLL rates, and life expectancy in 1990, and its relative position had worsened by 2010. Although in most age groups, there have been reductions in age-specific mortality, for men aged 30-34 years, mortality rates have hardly changed (reduction of 3•7%, 95% UI 2•7-4•9). In terms of premature mortality, worsening ranks are most notable for men and women aged 20-54 years. For all age groups, the contributions of Alzheimer's disease (increase of 137%, 16-277), cirrhosis (65%, -15 to 107), and drug use disorders (577%, 71-942) to premature mortality rose from 1990 to 2010. In 2010, compared with EU15+, the UK had significantly lower rates of age-standardised YLLs for road injury, diabetes, liver cancer, and chronic kidney disease, but significantly greater rates for ischaemic heart disease, chronic obstructive pulmonary disease, lower respiratory infections, breast cancer, other cardiovascular and circulatory disorders, oesophageal cancer, preterm birth complications, congenital anomalies, and aortic aneurysm. Because YLDs per person by age and sex have not changed substantially from 1990 to 2010 but age-specific mortality has been falling, the importance of chronic disability is rising. The major causes of YLDs in 2010 were mental and behavioural disorders (including substance abuse; 21•5% [95 UI 17•2-26•3] of YLDs), and musculoskeletal disorders (30•5% [25•5-35•7]). The leading risk factor in the UK was tobacco (11•8% [10•5-13•3] of DALYs), followed by increased blood pressure (9•0 % [7•5-10•5]), and high body-mass index (8•6% [7•4-9•8]). Diet and physical inactivity accounted for 14•3% (95% UI 12•8-15•9) of UK DALYs in 2010. Interpretation The performance of the UK in terms of premature mortality is persistently and significantly below the mean of EU15+ and requires additional concerted action. Further progress in premature mortality from several major causes, such as cardiovascular diseases and cancers, will probably require improved public health, prevention, early intervention, and treatment activities. The growing burden of disability, particularly from mental disorders, substance use, musculoskeletal disorders, and falls deserves an integrated and strategic response. Funding Bill &Melinda Gates Foundation.

    Original languageEnglish
    Pages (from-to)997-1020
    Number of pages24
    JournalThe Lancet
    Issue number9871
    Publication statusPublished - Mar 2013

    Bibliographical note

    Funding Information:
    Funding for this study was provided by the Bill & Melinda Gates Foundation. This research was done as part of GBD 2010; we would like to thank all individuals who have contributed to this study. We thank Duncan Selbie (Public Health England) for comments on drafts of the report; Muir Gray for comment, debate, and encouragement; and Richard Gleave and Jonathan Marron (Public Health England) for helping to frame the research questions.


    Dive into the research topics of 'UK health performance: Findings of the Global Burden of Disease Study 2010'. Together they form a unique fingerprint.

    Cite this